Drug factory · FDA FEI 3002807025

Fukuzyu Pharmaceutical Co., Ltd.

48, Hagihara, Toyama, Japan

Japan: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 11, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2013: 0 with no problems, 3 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
PyrimethamineMakes the active ingredient Oakrum Pharma, LLC, Vyera Pharmaceuticals LLC 72647-330, 69413-330

FDA inspection history

EndedResultProgramProblems noted
Nov 11, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 19, 2024Serious problems, FDA actionDrug Quality Assurance—
Jul 28, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 15, 2013Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.